Are we familiar with this rare indicative of a higher risk for breast cancer?
Yıl: 2019 Cilt: 5 Sayı: 3 Sayfa Aralığı: 562 - 565 Metin Dili: İngilizce DOI: 10.18621/eurj.424563 İndeks Tarihi: 27-04-2021
Are we familiar with this rare indicative of a higher risk for breast cancer?
Öz: Secretory adenosis (SA) of breast is rarely seen benign breast lesion, which might be associated with increasedrisk for breast carcinoma. SA is an extremely rare lesion, the cases reported in the literature and long-termfollow-up studies are limited and radiological and histopathological diagnosis of SA is mostly challenging; itcould be frequently misinterpreted as ductal carcinoma in situ. Because of these reasons; clinical significanceand management of SA is still not fully understand and relative risk of SA is still not well-established. Herein;we presented mammography, ultrasound, magnetic resonance imaging and microscopic findings in a patientwith SA of breast.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- [1] Tavassoli FA, Soares J. Myoepithelial Lesion: World Health Organization classification of Tumors. Pathology& Genetics. Tumors of the breast and Female Genital Organs. Lyon: International Agency for Research on Cancer (IARC); 2003:86- 8.
- [2] Moinfar F. Adenosis. In Essentials of Diagnostic Breast Pathology. Edited by: Moinfar F. Berlin: Springer; 2007:31.
- [3] Tsuda H, Mukai K, Fukutomi T, Hirohashi S. Malignant progression of adenomyoepithelial adenosis of the breast. Pathol Int 1994;44:475-9.
- [4] Tavassoli FA. Myoepithelial lesion of the breast. Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol 1991;15:554-68.
- [5] Page DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996;5:29-32.
- [6] Watanabe K, Nomura M, Hashimoto Y, Hanzawa M, Hoshi T. Fine needle aspiration cytology of apocrine adenosis of the breast: Report on three cases. Diagn Cytopathol 2007;35:296-9.
- [7] Mitra B, Pal M, Saha TN, Maiti A. Adenomyoepithelial adenosis of breast: a rare case report. Turk Patoloji Derg 2017;33:240-3.
- [8] Rosen PP. Rosen’s Breast Pathology. 3rd ed. Philadelphia: Lippincott Williams &Wilkins; 2008.
- [9] Calhoun BC, Booth NC. Atypical apocrine adenosis diagnosed on core biopsy: implications for management. Hum Pathol 2014;45:2130-5.
- [10] Seidman JD, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast: a clinico pathologic study of 37 patients with 8.7-year follow-up. Cancer 1996;77:2529-37.
- [11] Erel S, Tuncbilek I, Kismet K, Kilicoglu B, Ozer E, Akkus MA. Ademomyoepithelial adenosis of the breast: clinical, radiological, and pathological findings for diffrential diagnosis. Breast Care 2008;3:427-30.
- [12] Günhan-Bilgen I, Memiş A, Ustün EE, Ozdemir N, Erhan Y. Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 2002;44:232-8.
- [13] Chen JH, Nalcioglu O, Su MY. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging 2008;28:1499-505.
- [14] Gity M, Arabkheradmand A, Taheri E, Shakiba M, Khademi Y, Bijan B, et al. Magnetic resonance imaging features of adenosis in the breast. J Breast Cancer 2015;18:187-94.
- [15] Gillellamudi SB, Vellanki VS, Veeragandham S, Omar O. Apocrine adenosis of breast: a very rare case report. Int Surg J 2016;1:97-8.
| APA | Altunkeser A, Arslan F, Alkan E, GÜNLER T (2019). Are we familiar with this rare indicative of a higher risk for breast cancer?. , 562 - 565. 10.18621/eurj.424563 |
| Chicago | Altunkeser Ayşegül,Arslan Fatma Zeynep,Alkan Ender,GÜNLER TUĞBA Are we familiar with this rare indicative of a higher risk for breast cancer?. (2019): 562 - 565. 10.18621/eurj.424563 |
| MLA | Altunkeser Ayşegül,Arslan Fatma Zeynep,Alkan Ender,GÜNLER TUĞBA Are we familiar with this rare indicative of a higher risk for breast cancer?. , 2019, ss.562 - 565. 10.18621/eurj.424563 |
| AMA | Altunkeser A,Arslan F,Alkan E,GÜNLER T Are we familiar with this rare indicative of a higher risk for breast cancer?. . 2019; 562 - 565. 10.18621/eurj.424563 |
| Vancouver | Altunkeser A,Arslan F,Alkan E,GÜNLER T Are we familiar with this rare indicative of a higher risk for breast cancer?. . 2019; 562 - 565. 10.18621/eurj.424563 |
| IEEE | Altunkeser A,Arslan F,Alkan E,GÜNLER T "Are we familiar with this rare indicative of a higher risk for breast cancer?." , ss.562 - 565, 2019. 10.18621/eurj.424563 |
| ISNAD | Altunkeser, Ayşegül vd. "Are we familiar with this rare indicative of a higher risk for breast cancer?". (2019), 562-565. https://doi.org/10.18621/eurj.424563 |
| APA | Altunkeser A, Arslan F, Alkan E, GÜNLER T (2019). Are we familiar with this rare indicative of a higher risk for breast cancer?. The European Research Journal, 5(3), 562 - 565. 10.18621/eurj.424563 |
| Chicago | Altunkeser Ayşegül,Arslan Fatma Zeynep,Alkan Ender,GÜNLER TUĞBA Are we familiar with this rare indicative of a higher risk for breast cancer?. The European Research Journal 5, no.3 (2019): 562 - 565. 10.18621/eurj.424563 |
| MLA | Altunkeser Ayşegül,Arslan Fatma Zeynep,Alkan Ender,GÜNLER TUĞBA Are we familiar with this rare indicative of a higher risk for breast cancer?. The European Research Journal, vol.5, no.3, 2019, ss.562 - 565. 10.18621/eurj.424563 |
| AMA | Altunkeser A,Arslan F,Alkan E,GÜNLER T Are we familiar with this rare indicative of a higher risk for breast cancer?. The European Research Journal. 2019; 5(3): 562 - 565. 10.18621/eurj.424563 |
| Vancouver | Altunkeser A,Arslan F,Alkan E,GÜNLER T Are we familiar with this rare indicative of a higher risk for breast cancer?. The European Research Journal. 2019; 5(3): 562 - 565. 10.18621/eurj.424563 |
| IEEE | Altunkeser A,Arslan F,Alkan E,GÜNLER T "Are we familiar with this rare indicative of a higher risk for breast cancer?." The European Research Journal, 5, ss.562 - 565, 2019. 10.18621/eurj.424563 |
| ISNAD | Altunkeser, Ayşegül vd. "Are we familiar with this rare indicative of a higher risk for breast cancer?". The European Research Journal 5/3 (2019), 562-565. https://doi.org/10.18621/eurj.424563 |
